NEU 0.15% $13.13 neuren pharmaceuticals limited

Release Today Neuren Valuation Estimate Raised, page-63

  1. 915 Posts.
    lightbulb Created with Sketch. 254
    Well the experts are very exited by the data and what they saw , that’s is enough for me when u have no treatment options. The fda reconfirmed this by allowing p3 and last time I checked they don’t just hand out rubber stamps for p3.

    The problem is there is little in the pipeline to treat these conditions so I doubt pharma would let Neu pass just to wait and see if a competitor comes up with something better

    First mover advantage here will be huge
    Last edited by lilypily: 08/03/18
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.